Comparison of the immobilisation and cardiorespiratory effects of thiafentanil-azaperone versus thiafentanil-medetomidine-azaperone in African buffalo (Syncerus caffer)

Abstract

African buffalo (Syncerus caffer) are frequently immobilised for veterinary interventions, disease screening and translocations. Concerns over user and animal safety, costs, and irregularities in opioid supply, have led to the development of alternative immobilisation protocols. This study compared immobilisation of 12 boma-habituated African buffalo with thiafentanil-azaperone (TA) vs. thiafentanil-medetomidine-azaperone (TMA) in a randomised crossover study. Each buffalo received a combination of thiafentanil (6–7 mg) + azaperone (40 mg) and thiafentanil (1 mg) + medetomidine (3–4 mg) + azaperone (40 mg) with a three-week washout period between immobilisations. Induction and recovery times were recorded, quality of induction and immobilisation were scored subjectively, and physiological variables were monitored. The TMA combination induced immobilisation with 1/7th of the TA thiafentanil dose and at a quarter of the cost. Induction times for the TA combination were significantly faster at 5.7 ± 1.6 min and more reliable compared to the TMA combination at 10.95 ± 3.9 min. Both combinations resulted in severe hypoxaemia, however hypoxaemia was overall more pronounced in the TMA (PaO2 44 ± 14 mmHg) combination compared to the TA (PaO2 51 ± 13,33 mmHg) combination and resulted mainly from decreased pulmonary oxygen exchange rather than hypoventilation; PaCO2 values were mostly within the normal expected physiological range. Supplementary oxygen and close monitoring of blood oxygenation is considered essential with either combination. Although the reduction in costs could be beneficial for the wildlife industry, longer induction times, and risks from severe hypoxaemia need to be taken into consideration when the TMA combination is used.